Lan V Pham

Lan V Pham

UNVERIFIED PROFILE

Are you Lan V Pham?   Register this Author

Register author
Lan V Pham

Lan V Pham

Publications by authors named "Lan V Pham"

Are you Lan V Pham?   Register this Author

37Publications

730Reads

19Profile Views

Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).

J Autoimmun 2019 Aug 26;102:77-88. Epub 2019 Apr 26.

Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2019.04.020DOI Listing
August 2019

Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.

Clin Cancer Res 2018 08 17;24(16):3967-3980. Epub 2018 Apr 17.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3004DOI Listing
August 2018

The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.

Front Oncol 2018 8;8:147. Epub 2018 May 8.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951963PMC
May 2018

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

Am J Pathol 2017 Aug 13;187(8):1700-1716. Epub 2017 Jun 13.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; University of Texas School of Medicine, Graduate School of Biomedical Sciences, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530910PMC
August 2017

Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.

Am J Surg Pathol 2017 Feb;41(2):216-224

Departments of *Hematopathology †Pathology, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000758DOI Listing
February 2017

CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.

Oncotarget 2016 Nov;7(45):73558-73572

Division of Hematopoietic Stem Cell and Leukemia Research, Gehr Leukemia Center, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341999PMC
November 2016

Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.

J Hematol Oncol 2015 Oct 29;8:121. Epub 2015 Oct 29.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 54, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0218-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627381PMC
October 2015

In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasome.

Mol Cancer Ther 2013 Nov 29;12(11):2494-504. Epub 2013 Aug 29.

Corresponding Authors: Liang Zhang, Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0156DOI Listing
November 2013

Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.

Exp Hematol 2013 Jan 14;41(1):67-78.e4. Epub 2012 Sep 14.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.09.002DOI Listing
January 2013

The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.

Biochem Pharmacol 2012 Aug 9;84(4):451-8. Epub 2012 Jun 9.

Immunopharmacology and Targeted Therapy Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2012.05.019DOI Listing
August 2012

The role of BAFF-R dysregulation in B-lymphoid lineage malignancies.

Cell Cycle 2011 Jan 15;10(2):189-90. Epub 2011 Jan 15.

View Article

Download full-text PDF

Source
January 2011

An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.

Blood 2010 Nov 27;116(19):3899-906. Epub 2010 Jul 27.

Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-12-257378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981542PMC
November 2010

Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.

Mol Cancer Ther 2010 Jul 6;9(7):2026-36. Epub 2010 Jul 6.

Department of Hematopathology, Unit 54, The University of Texas of M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483974PMC
July 2010

Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Blood 2007 Sep 13;110(6):2121-7. Epub 2007 Jun 13.

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-02-073080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976364PMC
September 2007

Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes.

J Biol Chem 2006 Jul 27;281(27):18878-87. Epub 2006 Apr 27.

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M513315200DOI Listing
July 2006

Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Blood 2005 Dec 11;106(12):3940-7. Epub 2005 Aug 11.

Department of Hematopathology, Box 54, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-03-1167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895110PMC
December 2005

Assembly of the kappa preB receptor requires a V kappa-like protein encoded by a germline transcript.

J Biol Chem 2005 May 9;280(18):17807-14. Epub 2005 Mar 9.

Department of Immunology, M. D. Anderson Cancer Center, The University of Texas, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M409479200DOI Listing
May 2005

Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.

J Immunol 2003 Jul;171(1):88-95

Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.1.88DOI Listing
July 2003

A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.

Immunity 2002 Jan;16(1):37-50

Department of Hematopathology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1074-7613(01)00258-8DOI Listing
January 2002